Crestline Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-18,595
Closed -$2.1M 7
2024
Q4
$2.1M Buy
18,595
+5,071
+37% +$586K 0.07% 270
2024
Q3
$1.54M Buy
+13,524
New +$1.48M 0.08% 219
2018
Q3
Sell
-76,772
Closed -$4.68M 140
2018
Q2
$4.68M Buy
+76,772
New +$4.65M 0.49% 32

Other funds holding ABT

Crestline Management's ABT Position: Q1 2025 in Review

Crestline Management sold out of Abbott (ABT) in Q1 2025, closing a stake of 18,595 shares — an estimated $2.1M sold.

Crestline Management first reported a position in ABT in Q2 2018 and held it in 3 quarters. The position peaked at $4.68M in Q2 2018. 3,169 funds tracked by Wall St. Rank hold ABT as of Q1 2025.

  • Crestline Management reported no remaining Abbott position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 18,595 Abbott shares in Q1 2025, an estimated $2.1M.
  • Crestline Management first reported a position in Abbott in Q2 2018 and held it in 3 quarters.
  • Crestline Management's Abbott position peaked at $4.68M in Q2 2018.
  • 3,169 funds tracked by Wall St. Rank held Abbott as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.